ReviewThe pharmacogenomics journal2017

CYP3A4 is a crosslink between vitamin D and calcineurin inhibitors in solid organ transplant recipients: implications for bone health.

A Prytuła et al.PubMed ↗Publisher ↗

No numbers read from the abstract.